Patents by Inventor Gunter Koch

Gunter Koch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9130931
    Abstract: A method for reading at least one attribute stored in an ID token using first, second and third computer systems, wherein the third computer system comprises a browser and a client, and wherein a service certificate is assigned to the second computer system, wherein the service certificate comprises an identifier which is used to identify the second computer system, wherein the ID token is assigned to a user, a first cryptographically protected connection (TLS1) is set up between the browser of the third computer system and the second computer system, wherein the third computer system receives a first certificate, the first certificate is stored by the third computer system, the third computer system receives a signed attribute specification via the first connection, a second cryptographically protected connection (TLS2) is set up between the browser of the third computer system and the first computer system, wherein the third computer system receives a second certificate, the signed attribute specification i
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: September 8, 2015
    Assignee: BUNDESDRUCKEREI GmbH
    Inventors: Carsten Schwarz, Günter Koch
  • Publication number: 20150026476
    Abstract: A method for reading at least one attribute stored in an ID token using first, second and third computer systems, wherein the third computer system comprises a browser and a client, and wherein a service certificate is assigned to the second computer system, wherein the service certificate comprises an identifier which is used to identify the second computer system, wherein the ID token is assigned to a user,: a first cryptographically protected connection (TLS1) is set up between the browser of the third computer system and the second computer system, wherein the third computer system receives a first certificate, the first certificate is stored by the third computer system, the third computer system receives a signed attribute specification via the first connection, a second cryptographically protected connection (TLS2) is set up between the browser of the third computer system and the first computer system, wherein the third computer system receives a second certificate, the signed attribute specification
    Type: Application
    Filed: August 6, 2014
    Publication date: January 22, 2015
    Applicant: BUNDESDRUCKEREI GMBH
    Inventors: Carsten SCHWARZ, Günter KOCH
  • Patent number: 8812851
    Abstract: The invention relates to a method for reading at least one attribute stored in an ID token (106, 106?) using first (136), second (150) and third (100) computer systems, wherein the third computer system comprises a browser (112) and a client (113), and wherein a service certificate (144) is assigned to the second computer system, wherein the service certificate comprises an identifier which is used to identify the second computer system, wherein the ID token is assigned to a user (102), having the following steps: —a first cryptographically protected connection (TLS1) is set up between the browser of the third computer system and the second computer system, wherein the third computer system receives a first certificate (176), —the first certificate is stored by the third computer system, —the third computer system receives a signed attribute specification (182) via the first connection, —a second cryptographically protected connection (TLS2) is set up between the browser of the third computer system and the f
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: August 19, 2014
    Assignee: Bundesdruckerei GmbH
    Inventors: Carsten Schwarz, Günter Koch
  • Publication number: 20130219181
    Abstract: The invention relates to a method for reading at least one attribute stored in an ID token (106, 106?) using first (136), second (150) and third (100) computer systems, wherein the third computer system comprises a browser (112) and a client (113), and wherein a service certificate (144) is assigned to the second computer system, wherein the service certificate comprises an identifier which is used to identify the second computer system, wherein the ID token is assigned to a user (102), having the following steps: a first cryptographically protected connection (TLS1) is set up between the browser of the third computer system and the second computer system, wherein the third computer system receives a first certificate (176), the first certificate is stored by the third computer system, the third computer system receives a signed attribute specification (182) via the first connection, a second cryptographically protected connection (TLS2) is set up between the browser of the third computer system and the first
    Type: Application
    Filed: April 20, 2011
    Publication date: August 22, 2013
    Applicant: BUNDESDRUCKEREI GMBH
    Inventors: Carsten Schwarz, Günter Koch
  • Patent number: 8471033
    Abstract: The invention relates to a process for preparing the compound of formula 1 a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate.
    Type: Grant
    Filed: June 12, 2009
    Date of Patent: June 25, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Christian Filser, Wolfgang Dersch, Rainer Hamm, Arndt Hausherr, Gunter Koch, Ulrich Scholz, Georg Zerban
  • Patent number: 8354543
    Abstract: The invention relates to a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterized in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) i) the product thus obtained is hydrogenated and ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand; as well as a process for preparing a salt of an optionally substituted 4-(benzimidazol-2-ylmethylamino)-benzamidine, wherein (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) the product thus obtained is hydrogenated, and (c) i) optionally the amidino group is carbonylated and ii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.
    Type: Grant
    Filed: April 29, 2010
    Date of Patent: January 15, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Georg Zerban, Arndt Hausherr, Kerstin Schlarb, Rainer Hamm, Gunter Koch, Bjoem Weyell, Heinz-Peter Schmitt
  • Publication number: 20110118471
    Abstract: The invention relates to a process for preparing the compound of formula 1 a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate.
    Type: Application
    Filed: June 12, 2009
    Publication date: May 19, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Christian Filser, Wolfgang Dersch, Rainer Hamm, Arndt Hausherr, Gunter Koch, Ulrich Scholz, Georg Zerban
  • Patent number: 7880016
    Abstract: The invention relates to a process for preparing a salt of an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, b) i) the product thus obtained is hydrogenated, ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand and iii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: February 1, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Georg Zerban, Arndt Hausherr, Kerstin Schlarb, Rainer Hamm, Gunter Koch, Bjoern Weyell, Heinz-Peter Schmitt
  • Publication number: 20100282736
    Abstract: The invention relates to an electrically conductive foil made of a thermoplastic matrix and conductive reinforcement fibers, wherein the conductive fibers are disposed in the conductive foil in an approximately isotropic manner, and a method for the production thereof.
    Type: Application
    Filed: July 31, 2008
    Publication date: November 11, 2010
    Applicant: FRENZELIT-WERKE GMBH & CO. KG
    Inventors: Hans-Gunter Koch, Peter Ubelmesser
  • Patent number: 7799768
    Abstract: The present invention relates to crystalline polymorphs of 3-O-(3?,3?-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine salt (“DSB•2NMG)”), pharmaceutical compositions of the same and use of the same as an active pharmaceutical agent in the treatment of HIV related disorders.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: September 21, 2010
    Assignee: Myrexis, Inc.
    Inventors: Mike H. O'Neill, Gary G. Sweetapple, Randall M. Walker, Arndt Hausherr, Gunter Koch, David E. Martin
  • Publication number: 20100210845
    Abstract: The invention relates to a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) i) the product thus obtained is hydrogenated and ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand; as well as a process for preparing a salt of an optionally substituted 4-(benzimidazol-2-ylmethylamino)-benzamidine, wherein (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) the product thus obtained is hydrogenated, and (c) i) optionally the amidino group is carbonylated and ii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.
    Type: Application
    Filed: April 29, 2010
    Publication date: August 19, 2010
    Applicant: BOERINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Georg ZERBAN, Arndt HAUSHERR, Kerstin SCHLARB, Rainer HAMM, Gunter KOCH, Bjoem WEYELL, Heinz-Peter SCHMITT
  • Patent number: 7459566
    Abstract: A process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)benzamidine, the process comprising: (a) condensing an optionally suitably substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; (b) hydrogenating the product obtained from step (a); and (c) optionally carboxylating the amidino group of the product obtained from step (b).
    Type: Grant
    Filed: March 2, 2007
    Date of Patent: December 2, 2008
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Georg Zerban, Arndt Hausherr, Kerstin Schlarb, Heinz-Peter Schmitt, Bjoern Weyell, Gunter Koch, Rainer Hamm
  • Publication number: 20070185173
    Abstract: The invention relates to a process for preparing a salt of an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, b) i) the product thus obtained is hydrogenated, ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand and iii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.
    Type: Application
    Filed: December 21, 2006
    Publication date: August 9, 2007
    Inventors: Georg Zerban, Arndt Hausherr, Kerstin Schlarb, Rainer Hamm, Gunter Koch, Bjoern Weyell, Heinz-Peter Schmitt
  • Publication number: 20070185333
    Abstract: The invention relates to a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) i) the product thus obtained is hydrogenated and ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand; as well as a process for preparing a salt of an optionally substituted 4-(benzimidazol-2-ylmethylamino)-benzamidine, wherein (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) the product thus obtained is hydrogenated, and (c) i) optionally the amidino group is carbonylated and ii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.
    Type: Application
    Filed: December 21, 2006
    Publication date: August 9, 2007
    Inventors: Georg Zerban, Arndt Hausherr, Kerstin Schlarb, Rainer Hamm, Gunter Koch, Bjoern Weyell, Heinz-Peter Schmitt
  • Publication number: 20070149589
    Abstract: A process for preparing an optionally substituted 4-benzimidazol-2 -ylmethylamino)benzamidine, the process comprising: (a) condensing an optionally suitably substituted diaminobenzene with 2-[4-(1,2,4 -oxadiazol-5-on-3-yl)phenylamino]acetic acid; (b) hydrogenating the product obtained from step (a); and (c) optionally carboxylating the amidino group of the product obtained from step (b).
    Type: Application
    Filed: March 2, 2007
    Publication date: June 28, 2007
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Georg Zerban, Arndt Hausherr, Kerstin Schlarb, Heinz-Peter Schmitt, Bjoern Weyell, Gunter Koch, Rainer Hamm
  • Patent number: 7202368
    Abstract: A process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)benzamidine, the process comprising: (a) condensing an optionally suitably substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; (b) hydrogenating the product obtained from step (a); and (c) optionally carboxylating the amidino group of the product obtained from step (b).
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: April 10, 2007
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Georg Zerban, Arndt Hausherr, Kerstin Schlarb, Heinz-Peter Schmitt, Bjoern Weyell, Gunter Koch, Rainer Hamm
  • Publication number: 20060252704
    Abstract: The present invention relates to crystalline polymorphs of 3-O-(3?,3?-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine salt (“DSB•2NMG)”), pharmaceutical compositions of the same and use of the same as an active pharmaceutical agent in the treatment of HIV related disorders.
    Type: Application
    Filed: April 12, 2006
    Publication date: November 9, 2006
    Applicant: Panacos Pharmaceuticals, Inc.
    Inventors: Mike O'Neill, Gary Sweetapple, Randall Walker, Arndt Hausherr, Gunter Koch, David Martin
  • Publication number: 20060004064
    Abstract: A process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)benzamidine, the process comprising: (a) condensing an optionally suitably substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; (b) hydrogenating the product obtained from step (a); and (c) optionally carboxylating the amidino group of the product obtained from step (b).
    Type: Application
    Filed: June 9, 2005
    Publication date: January 5, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Georg Zerban, Arndt Hausherr, Kerstin Schlarb, Heinz-Peter Schmitt, Bjoern Weyell, Gunter Koch, Rainer Hamm
  • Publication number: 20040138216
    Abstract: Disclosed are improved processes for the preparation of a polymorph of 1-[tert-butyl-1-p-tolyl-1H-pyrazol-5-yl]-3-[4-(2-morpolinin-4-yl-ethoxy)naphthalen-1-yl]-urea (1) by crystallization from an alcohol, wherein the improvement is that crude (1) is treated with ethanol.
    Type: Application
    Filed: December 3, 2003
    Publication date: July 15, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Wendelin Samstag, Gunter Koch
  • Patent number: 4246238
    Abstract: A dissolver for dissolving nuclear fuel materials out of fuel element segments during reprocessing of irradiated nuclear fuels, the dissolver being made of a material which is a neutron absorber and being composed of a dissolving vessel and a dissolving basket disposed in the vessel to receive such fuel element segments and to permit flow of dissolving fluid therethrough, with the basket being divided into a plurality of individual sections or compartments so as to prevent establishment of a critical state in the dissolver.
    Type: Grant
    Filed: April 5, 1978
    Date of Patent: January 20, 1981
    Assignee: Kernforschungszentrum Karlsruhe GmbH
    Inventors: Hubert Goldacker, Gunter Koch, Helmut Schmieder, Ernst Warnecke, Walter Comper